European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update

M Rouprêt, M Babjuk, M Burger, O Capoun, D Cohen… - European urology, 2021 - Elsevier
Abstract Context The European Association of Urology (EAU) Guidelines Panel on Upper
Urinary Tract Urothelial Carcinoma (UTUC) has prepared updated guidelines to aid …

Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort …

C Tian, J Liu, L An, Y Hong, Q Xu - BMC urology, 2023 - Springer
Objective To establish a prognostic nomogram among UTUC patients who received
chemotherapy. Methods 1195 UTUC patients who received chemotherapy were extracted …

[HTML][HTML] Incidence, mortality and survival of transitional cell carcinoma in the urinary system: A population-based analysis

X Tang, X Zhan, X Chen - Medicine, 2023 - journals.lww.com
The goal of this study is exploring the disparity of incidence, mortality and survival outcome
among transitional cell carcinomas (TCCs) in the 4 parts of urinary system. This study …

A model for the prediction of survival in patients with upper tract urothelial carcinoma after surgery

G Zhang, W Zhou - Dose-Response, 2019 - journals.sagepub.com
Objective: We aimed to formulate and validate prognostic nomograms that can be used to
predict the prognosis of patients with upper tract urothelial carcinoma (UTUC). Methods: By …

Treatment of upper urinary tract urothelial carcinoma

SJ Crabb - The Lancet, 2020 - thelancet.com
a slow process. In the study by Phillips and colleagues, the median time to healing was 24
weeks (IQR 8–28) for RS8 and 16 weeks (IQR 8–25) for RC8. Practically, this result means …

MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?

A Cinque, A Capasso, R Vago, M Floris… - International Journal of …, 2022 - mdpi.com
Upper urinary tract urothelial carcinoma (UTUC) represents a minor subgroup of
malignancies arising in the urothelium of the renal pelvis or ureter. The estimated annual …

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: a microsimulation model

AE Hird, DE Magee, DC Cheung, B Sander… - Clinical Genitourinary …, 2021 - Elsevier
Background Upper tract urothelial carcinoma (UTUC) is clinically understudied, and there
are no definitive recommendations regarding timing of perioperative chemotherapy. The …

[PDF][PDF] Vena Kava Trombüslü Transizyonel Hücreli Böbrek Tümörü Olgusu

MF ŞIMŞEKOĞLU - books.akademisyen.net
Böbrek tümörleri, tanı yöntemlerinde sağlanan ilerlemelerle beraber son dönemde görülme
sıklığı artan hastalıklar arasındadır. Bu tümörler, geniş bir yaş aralığında görülebilse de …

[HTML][HTML] Perioperative systemic chemo‐immunotherapy for upper urinary tract urothelial carcinoma

EC Hwang, NJ Sathianathen, JH Jung… - The Cochrane …, 2020 - ncbi.nlm.nih.gov
Perioperative systemic chemo‐immunotherapy for upper urinary tract urothelial carcinoma -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

[HTML][HTML] Adjuvante Chemotherapie in der Behandlung der Urothelkarzinome des oberen Harntraktes

L Pape, J Richter, J Dunst - Strahlentherapie und …, 2020 - research.uni-luebeck.de
Hintergrund Beim Urothelkarzinom des oberen Harntraktes (UTUC) handelt es sich um eine
eher seltene maligne Erkrankung mit einer Inzidenz von 2 pro 100.000 Einwohnern pro …